Key result
VA-ECMO rescues a patient with refractory cardiogenic shock from Takotsubo syndrome during liver transplant.
Case Report (n=1)
No
VA-ECMO can be an effective rescue therapy for severe, refractory cardiogenic shock secondary to stress-induced (Takotsubo) cardiomyopathy during liver transplantation.
May support VA-ECMO in refractory post-transplant TTS; hypothesis-generating and leaves open broader applicability.
Here, we report the case of a 55 year old male patient without significant preexisting cardiovascular disease who received a deceased donor liver transplant. Intraoperatively, the patient developed cardiogenic shock secondary to stress-induced cardiomyopathy or Takotsubo syndrome (TTS), which was refractory to high-dose vasoactive, inotropic medical therapy. The patient was successfully managed with venoarterial extracorporeal membrane oxygenation (VA-ECMO) for 7 days, with complete recovery of cardiac function and maintenance of the hepatic graft. Given the anticipated need for only a short period of support and the expectation of full myocardial recovery, such patients may represent excellent candidates for the use of VA-ECMO.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a case report in Stress-induced (Takotsubo) cardiomyopathy with cardiogenic shock (n=1). Venoarterial extracorporeal membrane oxygenation (VA-ECMO) was evaluated on Recovery of cardiac function and maintenance of the hepatic graft. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) successfully rescued a patient with refractory cardiogenic shock from Takotsubo syndrome during a liver transplant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: